Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
6
MAZE Quote, Financials, Valuation and Earnings
Last price:
$28.72
Seasonality move
:
-7.25%
Day range:
$28.00 - $29.84
52-week range:
$6.71 - $53.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
501.13x
P/B ratio:
4.02x
Volume:
780.3K
Avg. volume:
980.7K
1-year change:
176.86%
Market cap:
$1.4B
Revenue:
--
EPS (TTM):
-$2.84
Earnings Data
Next earnings date for MAZE
May 06
2026
Most recent earnings per share
-$0.70
Missed by $0.01
(Mar 25/2026)
Consensus Estimate
-$0.69
(Mar 25/2026)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MAZE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2026 | Q2 | $500 | -- | -- | -$0.81 | -- |
| 05/06/2026 | Q1 | $8M | -- | -- | -$0.67 | -- |
| 03/25/2026 | Q4 | -- | -- | -$0.70 | -$0.69 | -$0.01 |
| 11/06/2025 | Q3 | -- | -- | -$0.63 | -$0.69 | $0.07 |
| 08/12/2025 | Q2 | $2.1M | -- | -$0.77 | -$1.16 | $0.39 |
| 05/14/2025 | Q1 | -- | -- | -$0.75 | -$0.63 | -$0.12 |
| 03/31/2025 | Q4 | -- | -- | -$0.11 | -- | -- |
| 09/30/2024 | Q3 | -- | $2.5M | -$0.06 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.74 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.61 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.57 | -- | -- |
Maze Therapeutics, Inc. Earnings Questions
-
How Much did Maze Therapeutics, Inc. Generate in Revenue Last Quarter?
Maze Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Maze Therapeutics, Inc. Beat Earnings Last Quarter?
Maze Therapeutics, Inc. announced earnings per share of -$0.70 which represents a miss of analyst forecast a -$0.69 per share.
-
Is Maze Therapeutics, Inc. Profitable?
Maze Therapeutics, Inc. reported -$499K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Maze Therapeutics, Inc. EPS Next Year?
Maze Therapeutics, Inc.'s earnings are forecast to decrease from -$2.66 per share to -$2.85 per share next year representing a decrease of -7.16%.
-
When is Maze Therapeutics, Inc.'s Earnings Date?
Maze Therapeutics, Inc.'s next earnings date is May 6, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 5
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 5
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 5
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
